Free Trial
NASDAQ:KRBP

Kiromic BioPharma (KRBP) Stock Price, News & Analysis

Kiromic BioPharma logo
$1.12
0.00 (0.00%)
(As of 11/4/2024 ET)

About Kiromic BioPharma Stock (NASDAQ:KRBP)

Key Stats

Today's Range
$1.12
$1.12
50-Day Range
$0.82
$2.09
52-Week Range
$0.18
$3.78
Volume
34 shs
Average Volume
5,023 shs
Market Capitalization
$1.73 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, utilizes engineered and non-engineered Gamma Delta T cell (GDT) technologies to develop therapies for solid tumors. The company develops Deltacel-01, which is in Phase 1 clinical trial, for patients with non-small cell lung cancer; Isocel in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; Procel in combination with low-dose radiation to treat PD-L1 positive solid malignancies; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has a license agreement with Longwood University; and a research and development collaboration agreement with Molipharma, S.R.L. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

Receive KRBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter.

KRBP Stock News Headlines

The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech giants are quietly integrating it. Venture capitalists are scrambling to invest.
See More Headlines

KRBP Stock Analysis - Frequently Asked Questions

Kiromic BioPharma's stock was trading at $0.87 on January 1st, 2024. Since then, KRBP stock has increased by 28.7% and is now trading at $1.12.
View the best growth stocks for 2024 here
.

Kiromic BioPharma, Inc. (NASDAQ:KRBP) posted its quarterly earnings data on Friday, August, 9th. The company reported ($0.74) earnings per share (EPS) for the quarter.

Kiromic BioPharma shares reverse split before market open on Monday, March 13th 2023. The 1-30 reverse split was announced on Monday, March 13th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Kiromic BioPharma (KRBP) raised $16 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 1,200,000 shares at a price of $12.00-$14.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO and Paulson Investment Company was co-manager.

Shares of KRBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Kiromic BioPharma investors own include Athenex (ATNX), KLX Energy Services (KLXE), Brainstorm Cell Therapeutics (BCLI), NGL Energy Partners (NGL), Orchard Therapeutics (ORTX), TherapeuticsMD (TXMD) and Achilles Therapeutics (ACHL).

Company Calendar

Last Earnings
8/09/2024
Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:KRBP
Fax
N/A
Employees
35
Year Founded
N/A

Profitability

Net Income
$-20,950,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($7.25) per share

Miscellaneous

Free Float
1,228,000
Market Cap
$1.73 million
Optionable
Not Optionable
Beta
1.97
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:KRBP) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners